12 Best Biotech Penny Stocks To Invest In Now
Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.
Omniab Inc. (OABI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Walleye Capital Will England | 0 | $0 | 0% | |
| 2. | Walleye Capital Will England | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.42 | 240,000 | Officer, Director | 3,536,665 | 2024-05-24 | Filing | |
| $5.19 | 225,000 | Officer, Director | 2,908,803 | 2024-03-22 | Filing | |
| $5.05 | 200,000 | Officer, Director | 2,645,442 | 2023-12-12 | Filing | |
| $4.27 | 95,000 | 2,427,919 | 2023-11-10 | Filing | ||
| $5.48 | 45,000 | Officer, Director | 2,332,919 | 2023-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.67 | 7,255 | Officer | 206,211 | 2025-02-19 | Filing | |
| $3.67 | 19,522 | Officer, Director | 3,779,160 | 2025-02-19 | Filing | |
| $3.68 | 13,964 | Officer, Director | 3,798,682 | 2025-02-18 | Filing | |
| $3.67 | 7,255 | Officer | 356,876 | 2025-02-19 | Filing | |
| $3.68 | 8,215 | Officer | 364,131 | 2025-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
OmniAb, Inc. (NASDAQ:OABI) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to OmniAb, Inc. Third Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
OmniAb, Inc. (NASDAQ:OABI) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to OmniAb Incorporated 2024 Financial Results and Business Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to OmniAb Inc. First Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
OmniAb, Inc. (NASDAQ:OABI) Q4 2023 Earnings Call Transcript
OmniAb, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.17.
OmniAb, Inc. (NASDAQ:OABI) Q3 2023 Earnings Call Transcript
Matthew Foehr: Okay, great, we're at 8 am Pacific Time, 11 am Eastern time. So we will kick it off. Good morning everyone.
OmniAb, Inc. (NASDAQ:OABI) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to OmniAb, Inc. Second Quarter 2023 Financial Results and Business Update Conference Call.
Hedge Fund and Insider Trading News: Crispin Odey, George Soros, Cathie Wood, Arex Capital Management, Akoya Biosciences Inc (AKYA), Satsuma Pharmaceuticals, Inc. (STSA), and More
Hedge fund Arex Capital Management is urging Enhabit (EHAB.N) to put itself up for sale and wants the home health and hospice provider to begin a strategic review to help reverse a 50% slide in its share...
OmniAb, Inc. (NASDAQ:OABI) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the OmniAb Inc.'s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
